Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.

Saved in:
Bibliographic Details
Title: Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three Decades.
Authors: Bialer M; Institute of Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. bialer@md.huji.ac.il.; David R. Bloom Center for Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel. bialer@md.huji.ac.il., Perucca E; Department of Medicine (Austin Health), The University of Melbourne, Melbourne, VIC, Australia.; Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.
Source: Drugs [Drugs] 2026 May; Vol. 86 (5), pp. 599-625. Date of Electronic Publication: 2026 Mar 01.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-1950
DOI:10.1007/s40265-026-02297-y